Evaluating the effects of curcumin nanomicelles on clinical outcome and cellular immune responses in critically ill sepsis patients: a randomized, double-blind, and placebo-controlled trial

HIGHLIGHTS

• who: Arash Karimi and collaborators from the University of Trieste, Italy have published the article: Evaluating the effects of curcumin nanomicelles on clinical outcome and cellular immune responses in critically ill sepsis patients: A randomized, double-blind, and placebo-controlled trial, in the Journal: Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran, 4 Student of 06/Dec/2022
• what: The aim of this study was to investigate the impacts of curcumin nanomicelles on clinical outcomes and cellular immune_responses in critically ill sepsis patients. In the present study, Human IL-17 and IL . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.